Oaktree Acquisition Corp. III Life Sciences (OACCU) EBT (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly EBT came in at $1.4 million in Q1 2026, down 15.96% YoY from $1.7 million in Q1 2025, and down 22.07% on a QoQ basis from $1.8 million in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) EBT (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 2 years of EBT data on file, last reported at $1.4 million in Q1 2026.
- Quarterly EBT fell 15.96% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (changed N/A YoY) and the FY2025 annual result came in at $7.3 million, up 489.27% from the prior year.
- EBT retreated to $1.4 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, EBT ranged from a high of $2.0 million in Q3 2025 to a low of $1.4 million in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.66 Mn |